Hydrochloric Acid → 4-Piperidin-1-yl-but-2-enoic acid-HCl
반응식
C[O:2][C:3](=[O:13])[CH:4]=[CH:5][CH2:6][N:7]1[CH2:12][CH2:11][CH2:10][CH2:9][CH2:8]1.[ClH:14]>>[ClH:14].[N:7]1([CH2:6][CH:5]=[CH:4][C:3]([OH:13])=[O:2])[CH2:12][CH2:11][CH2:10][CH2:9][CH2:8]1참가 물질
3
실험 절차
4-Piperidin-1-yl-but-2-enoic acid methyl ester (2.05 g, 11.2 mmol) and concentrated hydrochloric acid (10 mL) were combined in dioxanes (30 mL) and heated to reflux overnight. The mixture was concentrated in vacuo. The residue was crystallized from IPA to yield the desired product (390 mg, 17%). 400 MHz 1H NMR (DMSO-d6) δ 6.80 (dt, 1H, J=15.6, 7.1 Hz), 6.14 (d, 1H, J=15.6 Hz), 3.85 (d, 1H, J=7.1 Hz), 2.89 (m, 4H), 1.54 (m, 6H). MS m/z 170 (M+1).
후처리
- temperatureheated
- temperatureto reflux overnight
- concentrationThe mixture was concentrated in vacuo
- customThe residue was crystallized from IPA
출처 및 근거
- ORD 기록
- ord-04ac8d251b934e5ebf7ed767bda7eb9f
- 출처 데이터셋
- uspto-grants-2014_01
- 특허 번호
- US08623883B2
반응 노트
불러오는 중…